{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:18:45Z","timestamp":1758845925727,"version":"3.44.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-025-04517-y","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T20:32:26Z","timestamp":1745267546000},"page":"3131-3142","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of angiogenin in bladder cancer: where are we in 2025?"],"prefix":"10.1007","volume":"57","author":[{"given":"Thomas R.","family":"Wong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Braian","family":"Ledesma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaha","family":"Isali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,22]]},"reference":[{"issue":"1","key":"4517_CR1","first-page":"15","volume":"8","author":"K Saginala","year":"2020","unstructured":"Saginala K, Barsouk A, Aluru JS, Rawla P, Padala SA, Barsouk A (2020) Epidemiology of bladder cancer. Med Sci (Basel) 8(1):15","journal-title":"Med Sci (Basel)"},{"issue":"1","key":"4517_CR2","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1038\/s41598-018-19199-z","volume":"8","author":"MCS Wong","year":"2018","unstructured":"Wong MCS, Fung FDH, Leung C, Cheung WWL, Goggins WB, Ng CF (2018) The global epidemiology of bladder cancer: a joinpoint regression analysis of its incidence and mortality trends and projection. Sci Rep 8(1):1129","journal-title":"Sci Rep"},{"key":"4517_CR3","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.3389\/fgene.2019.01237","volume":"10","author":"R Batista","year":"2019","unstructured":"Batista R, Vinagre J, Prazeres H, Sampaio C, Peralta P, Concei\u00e7\u00e3o P, Sismeiro A, Le\u00e3o R, Gomes A, Furriel F, Oliveira C, Torres JN, Eufr\u00e1sio P, Azinhais P, Almeida F, Gonzalez ER, Bidovanets B, Ecke T, Stinjs P, Pascual S\u00c1, Abdelmalek R, Villafruela A, Beardo-Villar P, Fidalgo N, \u00d6zt\u00fcrk H, Gonzalez-Enguita C, Monzo J, Lopes T, \u00c1lvarez-Maestro M, Servan PP, De La Cruz SMP, Perez MPS, M\u00e1ximo V, Soares P (2019) Validation of a novel, sensitive, and specific urine-based test for recurrence surveillance of patients with non-muscle-invasive bladder cancer in a comprehensive multicenter study. Front Genet 10:1237","journal-title":"Front Genet"},{"key":"4517_CR4","doi-asserted-by":"publisher","first-page":"1984718","DOI":"10.1155\/2018\/1984718","volume":"2018","author":"D Yu","year":"2018","unstructured":"Yu D, Cai Y, Zhou W, Sheng J, Xu Z (2018) The potential of angiogenin as a serum biomarker for diseases: systematic review and meta-analysis. Dis Markers 2018:1984718","journal-title":"Dis Markers"},{"issue":"4","key":"4517_CR5","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/PPO.0000000000000138","volume":"21","author":"DR Bielenberg","year":"2015","unstructured":"Bielenberg DR, Zetter BR (2015) The contribution of angiogenesis to the process of metastasis. Cancer J (Sudbury, Mass.) 21(4):267\u2013273","journal-title":"Cancer J (Sudbury, Mass.)"},{"issue":"7","key":"4517_CR6","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1038\/onc.2014.2","volume":"34","author":"M Miyake","year":"2015","unstructured":"Miyake M, Goodison S, Lawton A, Gomes-Giacoia E, Rosser CJ (2015) Angiogenin promotes tumoral growth and angiogenesis by regulating matrix metallopeptidase-2 expression via the ERK1\/2 pathway. Oncogene 34(7):890\u2013901","journal-title":"Oncogene"},{"issue":"2","key":"4517_CR7","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s10735-014-9608-x","volume":"46","author":"J Shu","year":"2015","unstructured":"Shu J, Huang M, Tian Q, Shui Q, Zhou Y, Chen J (2015) Downregulation of angiogenin inhibits the growth and induces apoptosis in human bladder cancer cells through regulating AKT\/mTOR signaling pathway. J Mol Histol 46(2):157\u2013171","journal-title":"J Mol Histol"},{"issue":"12","key":"4517_CR8","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1016\/j.cellsig.2014.08.021","volume":"26","author":"Y Peng","year":"2014","unstructured":"Peng Y, Li L, Huang M, Duan C, Zhang L, Chen J (2014) Angiogenin interacts with ribonuclease inhibitor regulating PI3K\/AKT\/mTOR signaling pathway in bladder cancer cells. Cell Signal 26(12):2782\u20132792","journal-title":"Cell Signal"},{"issue":"8","key":"4517_CR9","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.3390\/ijms17081278","volume":"17","author":"P Koczera","year":"2016","unstructured":"Koczera P, Martin L, Marx G, Schuerholz T (2016) The Ribonuclease A superfamily in humans: canonical RNases as the buttress of innate immunity. Int J Mol Sci 17(8):1278","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4517_CR10","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ygeno.2004.10.008","volume":"85","author":"S Cho","year":"2005","unstructured":"Cho S, Beintema JJ, Zhang J (2005) The ribonuclease A superfamily of mammals and birds: identifying new members and tracing evolutionary histories. Genomics 85(2):208\u2013220","journal-title":"Genomics"},{"issue":"18","key":"4517_CR11","doi-asserted-by":"publisher","first-page":"10407","DOI":"10.1073\/pnas.95.18.10407","volume":"95","author":"PA Leland","year":"1998","unstructured":"Leland PA, Schultz LW, Kim BM, Raines RT (1998) Ribonuclease A variants with potent cytotoxic activity. Proc Natl Acad Sci U S A 95(18):10407\u201310412","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"4517_CR12","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1111\/j.1538-7836.2006.01995.x","volume":"4","author":"A Tello-Montoliu","year":"2006","unstructured":"Tello-Montoliu A, Patel JV, Lip GYH (2006) Angiogenin: a review of the pathophysiology and potential clinical applications. J Thromb Haemost 4(9):1864\u20131874","journal-title":"J Thromb Haemost"},{"issue":"28","key":"4517_CR13","doi-asserted-by":"publisher","first-page":"43109","DOI":"10.18632\/oncotarget.10097","volume":"7","author":"R Peres","year":"2016","unstructured":"Peres R, Furuya H, Pagano I, Shimizu Y, Hokutan K, Rosser CJ (2016) Angiogenin contributes to bladder cancer tumorigenesis by DNMT3b-mediated MMP2 activation. Oncotarget 7(28):43109\u201343123","journal-title":"Oncotarget"},{"issue":"4","key":"4517_CR14","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s12253-014-9765-y","volume":"20","author":"MI Shabayek","year":"2014","unstructured":"Shabayek MI, Sayed OM, Attaia HA, Awida HA, Abozeed H (2014) Diagnostic Evaluation of Urinary Angiogenin (ANG) and Clusterin (CLU) as Biomarker for Bladder Cancer. Pathology & Oncology Research 20(4):859\u2013866","journal-title":"Pathology & Oncology Research"},{"issue":"9","key":"4517_CR15","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.clinbiochem.2004.05.027","volume":"37","author":"S Eissa","year":"2004","unstructured":"Eissa S, Kenawy G, Swellam M, El-Fadle AA, Abd El-Aal AA, El-Ahmady O (2004) Comparison of cytokeratin 20 RNA and angiogenin in voided urine samples as diagnostic tools for bladder carcinoma. Clin Biochem 37(9):803\u2013810","journal-title":"Clin Biochem"},{"issue":"5","key":"4517_CR16","doi-asserted-by":"publisher","first-page":"1185.e1","DOI":"10.1016\/j.urology.2012.01.016","volume":"79","author":"V Urquidi","year":"2012","unstructured":"Urquidi V, Goodison S, Kim J, Chang M, Dai Y, Rosser CJ (2012) Vascular endothelial growth factor, carbonic anhydrase 9, and angiogenin as urinary biomarkers for bladder cancer detection. Urology 79(5):1185.e1-1185.e11856","journal-title":"Urology"},{"issue":"4","key":"4517_CR17","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3390\/diagnostics9040166","volume":"9","author":"H Furuya","year":"2019","unstructured":"Furuya H, Pagano I, Chee K, Kobayashi T, Wong RS, Lee R, Rosser CJ (2019) Comparison of commercial ELISA kits, a prototype multiplex electrochemoluminescent assay, and a multiplex bead-based immunoassay for detecting a urine-based bladder-cancer-associated diagnostic signature. Diagnostics 9(4):166","journal-title":"Diagnostics"},{"issue":"1","key":"4517_CR18","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12967-023-04811-2","volume":"22","author":"H Furuya","year":"2024","unstructured":"Furuya H, Sakatani T, Tanaka S, Murakami K, Waldron RT, Hogrefe W, Rosser CJ (2024) Bladder cancer risk stratification with the Oncuria 10-plex bead-based urinalysis assay using three different Luminex xMAP instrumentation platforms. J Transl Med 22(1):8","journal-title":"J Transl Med"},{"issue":"1","key":"4517_CR19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12967-016-0783-2","volume":"14","author":"Y Shimizu","year":"2016","unstructured":"Shimizu Y, Furuya H, Bryant Greenwood P, Chan O, Dai Y, Thornquist MD, Goodison S, Rosser CJ (2016) A multiplex immunoassay for the non-invasive detection of bladder cancer. J Translat Med 14(1):31","journal-title":"J Translat Med"},{"issue":"10","key":"4517_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0047469","volume":"7","author":"S Goodison","year":"2012","unstructured":"Goodison S, Chang M, Dai Y, Urquidi V, Rosser CJ (2012) A multi-analyte assay for the non-invasive detection of bladder cancer. PLoS ONE 7(10):e47469","journal-title":"PLoS ONE"},{"key":"4517_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2024.110780","volume":"130","author":"AH Aalami","year":"2024","unstructured":"Aalami AH, Abdeahad H, Aalami F, Sathyapalan T, Sahebkar A (2024) Investigating angiogenin\/ribonuclease 5 as a diagnostic biomarker for bladder cancer: In-depth analysis from a systematic review and meta-analysis. Clin Biochem 130:110780","journal-title":"Clin Biochem"},{"key":"4517_CR22","doi-asserted-by":"publisher","first-page":"4848752","DOI":"10.1155\/2020\/4848752","volume":"2020","author":"B Szyma\u0144ska","year":"2020","unstructured":"Szyma\u0144ska B, Sawicka E, Matuszewski M, Dembowski J, Piwowar A (2020) The dependence between urinary levels of angiogenesis factors, 8-Iso-prostaglandin F2\u03b1, \u0263-synuclein, and interleukin-13 in patients with bladder cancer: a pilot study. J Oncol 2020:4848752","journal-title":"J Oncol"},{"issue":"6","key":"4517_CR23","doi-asserted-by":"publisher","first-page":"7101","DOI":"10.18632\/oncotarget.23872","volume":"9","author":"N Masuda","year":"2018","unstructured":"Masuda N, Ogawa O, Park M, Liu AY, Goodison S, Dai Y, Kozai L, Furuya H, Lotan Y, Rosser CJ, Kobayashi T (2018) Meta-analysis of a 10-plex urine-based biomarker assay for the detection of bladder cancer. Oncotarget 9(6):7101\u20137111","journal-title":"Oncotarget"},{"key":"4517_CR24","doi-asserted-by":"publisher","first-page":"5557309","DOI":"10.1155\/2021\/5557309","volume":"2021","author":"AH Aalami","year":"2021","unstructured":"Aalami AH, Abdeahad H, Mesgari M, Sathyapalan T, Sahebkar A (2021) Urinary angiogenin as a marker for bladder cancer: a meta-analysis. Biomed Res Int 2021:5557309\u20135557309","journal-title":"Biomed Res Int"},{"issue":"1\u20132","key":"4517_CR25","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11010-010-0663-7","volume":"349","author":"J Chen","year":"2011","unstructured":"Chen J, Ou-Yang X, Gao J, Zhu J, He X, Rong J (2011) Knockdown of ribonuclease inhibitor expression with siRNA in non-invasive bladder cancer cell line BIU-87 promotes growth and metastasis potentials. Mol Cell Biochem 349(1\u20132):83\u201395","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"4517_CR26","doi-asserted-by":"publisher","first-page":"12625","DOI":"10.1038\/s41598-023-39827-7","volume":"13","author":"S Chen","year":"2023","unstructured":"Chen S, Ran J, Fan Z, Liu M, Wu L, Li Q, Peng J, Hu Z (2023) Functional status analysis of RNH1 in bladder cancer for predicting immunotherapy response. Sci Rep 13(1):12625","journal-title":"Sci Rep"},{"key":"4517_CR27","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.biochi.2014.04.007","volume":"103","author":"L Li","year":"2014","unstructured":"Li L, Pan X-Y, Shu J, Jiang R, Zhou Y-J, Chen J-X (2014) Ribonuclease inhibitor up-regulation inhibits the growth and induces apoptosis in murine melanoma cells through repression of angiogenin and ILK\/PI3K\/AKT signaling pathway. Biochimie 103:89\u2013100","journal-title":"Biochimie"},{"issue":"7","key":"4517_CR28","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s11912-023-01421-5","volume":"25","author":"G Elayat","year":"2023","unstructured":"Elayat G, Punev I, Selim A (2023) An overview of angiogenesis in bladder cancer. Curr Oncol Rep 25(7):709\u2013728","journal-title":"Curr Oncol Rep"},{"issue":"5","key":"4517_CR29","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1093\/abbs\/gmv131","volume":"48","author":"J Sheng","year":"2016","unstructured":"Sheng J, Xu Z (2016) Three decades of research on angiogenin: a review and perspective. Acta Biochim Biophys Sin 48(5):399\u2013410","journal-title":"Acta Biochim Biophys Sin"},{"issue":"11","key":"4517_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0141253","volume":"10","author":"C Costa","year":"2015","unstructured":"Costa C, Pereira S, Lima L, Peixoto A, Fernandes E, Neves D, Neves M, Gaiteiro C, Tavares A, Gil da Costa RM, Cruz R, Amaro T, Oliveira PA, Ferreira JA, Santos LL (2015) Abnormal protein glycosylation and activated PI3K\/Akt\/mTOR pathway: role in bladder cancer prognosis and targeted therapeutics. PLoS ONE 10(11):e0141253","journal-title":"PLoS ONE"},{"key":"4517_CR31","doi-asserted-by":"crossref","unstructured":"M. Stillinovic, M.A. Sarangdhar, N. Andina, A. Tardivel, F. Greub, G. Bombaci, C. Ansermet, M. Heller, A. Keogh, I. Keller, A. Angelillo-Scherrer, R. Allam, Ribonuclease Inhibitor and Angiogenin collaboratively regulate cell-type-specific global translation, bioRxiv (2024) 2024.03.29.586999.","DOI":"10.1101\/2024.03.29.586999"},{"issue":"4","key":"4517_CR32","doi-asserted-by":"publisher","first-page":"362","DOI":"10.30699\/ijp.2021.138671.2518","volume":"16","author":"A Sadaf","year":"2021","unstructured":"Sadaf A, Rahman MZ, Bhattacharjee P, Ahamad MSU, Nasreen S (2021) Significance of vascular endothelial growth factor expression in the bladder urothelial carcinoma and its association with tumor grade and invasiveness. Iran J Pathol 16(4):362\u2013369","journal-title":"Iran J Pathol"},{"issue":"1","key":"4517_CR33","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41392-023-01460-1","volume":"8","author":"Z-L Liu","year":"2023","unstructured":"Liu Z-L, Chen H-H, Zheng L-L, Sun L-P, Shi L (2023) Angiogenic signaling pathways and anti-angiogenic therapy for cancer. Signal Transduct Target Ther 8(1):198","journal-title":"Signal Transduct Target Ther"},{"key":"4517_CR34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12967-016-0783-2","volume":"14","author":"Y Shimizu","year":"2016","unstructured":"Shimizu Y, Furuya H, Bryant Greenwood P, Chan O, Dai Y, Thornquist MD, Goodison S, Rosser CJ (2016) A multiplex immunoassay for the non-invasive detection of bladder cancer. J Transl Med 14:31","journal-title":"J Transl Med"},{"issue":"1","key":"4517_CR35","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/cncr.21136","volume":"104","author":"H Zhao","year":"2005","unstructured":"Zhao H, Grossman HB, Delclos GL, Hwang L-Y, Troisi CL, Chamberlain RM, Chenoweth MA, Zhang H, Spitz MR, Wu X (2005) Increased plasma levels of angiogenin and the risk of bladder carcinoma. Cancer 104(1):30\u201335","journal-title":"Cancer"},{"issue":"2","key":"4517_CR36","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s12253-019-00620-5","volume":"26","author":"E Sawicka","year":"2020","unstructured":"Sawicka E, Kratz EM, Szyma\u0144ska B, Guzik A, Weso\u0142owski A, Kowal P, Pawlik-Sobecka L, Piwowar A (2020) Preliminary study on selected markers of oxidative stress, inflammation and angiogenesis in patients with bladder cancer. Pathol Oncol Res 26(2):821\u2013831","journal-title":"Pathol Oncol Res"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04517-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-025-04517-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04517-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:59:46Z","timestamp":1758808786000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-025-04517-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,22]]},"references-count":36,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["4517"],"URL":"https:\/\/doi.org\/10.1007\/s11255-025-04517-y","relation":{},"ISSN":["1573-2584"],"issn-type":[{"type":"electronic","value":"1573-2584"}],"subject":[],"published":{"date-parts":[[2025,4,22]]},"assertion":[{"value":"2 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no funding received or conflicts of interest for the submitted study. Conceptualization: Ilaha Isali. Literature search: Thomas R. Wong, Clara Sun. Drafted the manuscript: Thomas R. Wong, Ilaha Isali. Revised manuscript: all. Supervision: Ilaha Isali.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}